Minimal Effective Dose

Minimal Effective Dose is a dosing concept in immuno-oncology that denotes the lowest dose of an immunotherapeutic agent required to achieve a clinically meaningful and sustained antitumor immune response.

802

Publications

36K

Citations

3.4K

Authors

1.1K

Institutions

Publications per year

2017–2026

90

Authors

3.4K

  1. SM
    Samuel M. McCann

    The University of Texas Southwestern Medical Center, United States

    8 publications · 360 citations

    8

    h-index

  2. DR
    Daniel Rudman

    Emory University, United States

    6 publications · 131 citations

    6

    h-index

  3. RD
    Roger D. Reidelberger

    Creighton University, United States

    5 publications · 361 citations

    5

    h-index

  4. JM
    John M. Kane

    Zucker Hillside Hospital, United States

    3 publications · 198 citations

    3

    h-index

  5. JM
    Jim Mintz

    University of California, Los Angeles, United States

    3 publications · 152 citations

    3

    h-index

1–5 of 3.4K

Venues

  1. PubMed

    Repository · 91 publications · 3.1K citations

    30

    h-index

  2. Antimicrobial Agents and Chemotherapy

    AAC · 24 publications · 1.3K citations

    21

    h-index

  3. Endocrinology

    30 publications · 1.4K citations

    19

    h-index

  4. 17

    h-index

  5. British Journal of Dermatology

    17 publications · 747 citations

    15

    h-index

1–5